These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 10130839)
1. Can price and regulatory controls replace free market competition in the drug industry? Buc NL; Levitt GM Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839 [No Abstract] [Full Text] [Related]
2. The need for health care reform. Mossinghoff GJ Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516 [No Abstract] [Full Text] [Related]
3. Health care reform and the pharmaceutical industry. Mossinghoff GJ Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353 [TBL] [Abstract][Full Text] [Related]
5. Prescription-drug prices. Frank RG N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294 [No Abstract] [Full Text] [Related]
6. Medicare and prescription drugs. Iglehart JK N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630 [No Abstract] [Full Text] [Related]
7. Prescription drug pricing: do competitive forces operate in the pharmaceutical marketplace? Margolis RE Healthspan; 1994 Feb; 11(2):9-16. PubMed ID: 10132991 [No Abstract] [Full Text] [Related]
8. PBMs get new role. Seen as key to drug cost control under new benefit. Becker C Mod Healthc; 2003 Dec 22-29; 33(51):31, 33. PubMed ID: 14723089 [No Abstract] [Full Text] [Related]
9. Opinion: price controls on prescription drugs. Franks B N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791 [No Abstract] [Full Text] [Related]
10. Prescription drug talk cooled off faster than a Texas thunderstorm. Levin-Epstein M Manag Care; 2001 May; 10(5):14-6. PubMed ID: 11392723 [No Abstract] [Full Text] [Related]
12. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly. DoBias M Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495 [No Abstract] [Full Text] [Related]
13. Pharmaceuticals and medical devices: Medicare Part D. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447 [No Abstract] [Full Text] [Related]
17. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs. Mello MM; Studdert DM; Brennan TA N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190 [No Abstract] [Full Text] [Related]
18. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices. Sarpatwari A; Avorn J; Kesselheim AS JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027 [No Abstract] [Full Text] [Related]
19. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs. Gudiksen KL; King JS J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534 [No Abstract] [Full Text] [Related]